image
Avadel Pharmaceuticals plc AVDL
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IE
Watchlist
$ 10.91
-5.87 %
$ 1.05 B
Market Cap
-10.01
P/E
BALANCE SHEET
165 M ASSETS
24.03%
Growth Rates
1Year 24.03%
3Years -19.15%
5Years -2.85%
7Years -5.54%
10Years 3.54%
77 M LIABILITIES
-50.00%
Growth Rates
1Year -50.00%
3Years -19.83%
5Years -16.32%
7Years -12.96%
10Years -4.79%
87.7 M EQUITY
514.94%
Growth Rates
1Year 514.94%
3Years -18.53%
5Years 99.45%
7Years 11.07%
10Years 27.35%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Avadel Pharmaceuticals plc
image
Current Assets 134 M
Cash & Short-Term Investments 105 M
Receivables 13.4 M
Other Current Assets 15.7 M
Non-Current Assets 30.5 M
Long-Term Investments 0
PP&E 3.18 M
Other Non-Current Assets 27.3 M
Current Liabilities 36.9 M
Accounts Payable 11.4 M
Short-Term Debt 1.87 M
Other Current Liabilities 23.6 M
Non-Current Liabilities 40.1 M
Long-Term Debt 34.4 M
Other Non-Current Liabilities 5.65 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
ASSETS
Cash & Cash Equivalents 31.2 74.0 50.7 71.7 9.8 9.3 16.6 39.2 65.1 39.8 6.6 2.7 3.5 8.2 8.7 27.0 26.3 51.8 1.0 4.6 109.6 14.5 5.3 10.1 5.2 7.3 3.8 15.5
Short Term Investments 73.9 22.5 106.5 149.7 54.4 90.6 77.5 115.0 79.7 53.1 0.4 6.4 21.0 23.2 35.4 10.1 14.7 10.9 82.8 100.8 0 0 0 0 0 0 0 0
Receivables 13.4 0 0 3.3 8.3 13.9 16.5 17.8 7.5 8.7 21.0 13.2 9.3 11.4 20.3 19.3 12.1 9.0 2.6 8.2 8.4 3.5 7.6 2.6 1.6 3.2 3.3 1.0
Inventory 10.4 0 0 0 3.6 4.8 6.2 3.3 4.2 6.7 3.8 1.5 1.7 0.9 1.1 1.8 1.8 3.3 1.1 1.6 1.1 0.4 0.6 0.9 0.2 0.8 100 K 0.2
Other Current Assets 5.3 4.3 35.3 3.3 6.4 6.3 7.2 5.9 10.4 4.1 3.1 1.2 1.2 1.7 1.4 1.0 1.1 1.4 4.6 5.6 1.7 0.3 0.3 0.4 0.7 5.2 7.4 1.1
Total Current Assets 134.2 100.8 192.5 263.5 82.4 124.9 124.0 181.2 166.3 112.3 33.6 25.1 36.7 45.4 66.8 59.2 56.1 76.8 92.0 120.8 120.7 18.7 13.8 14.1 7.8 16.4 14.6 17.8
PP&E 3.2 2.6 2.9 3.0 4.2 7.8 3.0 3.3 2.6 1.8 17.4 18.2 19.4 21.4 24.8 27.6 35.1 25.7 22.3 18.2 5.1 3.4 2.7 2.9 3.5 4.6 4.1 1.7
Intangible Assets 0 0 0 0 0.8 1.6 92.3 22.8 15.8 28.4 40.1 41.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 K 0.2
Goodwill 16.8 16.8 16.8 16.8 18.5 18.5 18.5 18.5 18.5 18.5 18.5 18.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 1.2 (22.9) (14.8) (23.1) 8.7 1.4 1.8 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 10.5 (60.0) 33.8 24.9 39.3 5.7 9.1 7.5 0.2 0.1 6.6 13.9 13.2 7.8 2.7 5.1 10.2 12.4 10.0 6.7 1.4 1.0 1.7 3.4 3.7 4.3 2.7 10.2
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 164.7 132.8 247.3 311.6 151.4 190.3 252.1 245.5 215.0 174.2 116.3 117.3 69.4 74.6 94.3 91.9 101.4 114.9 124.4 145.6 127.3 23.1 18.1 20.4 14.9 25.3 21.5 29.9
LIABILITIES
Accounts Payable 11.4 7.9 7.7 2.9 6.1 3.5 7.5 7.1 5.0 8.0 5.1 3.6 3.9 4.9 6.4 5.8 8.6 9.7 11.5 9.7 4.4 1.3 1.2 1.5 1.5 2.6 2.5 3.1
Short Term Debt 1.9 39.6 1.8 0.9 1.3 0.1 0.1 0.3 0.4 42.4 26.3 3.5 2.2 2.4 0.9 0.8 1.0 0.4 0.8 0.6 0.3 0.9 0.8 0.6 0.5 0.4 0.4 0.4
Other Current Liabilities 23.6 8.3 11.5 11.2 28.6 34.6 76.7 51.6 34.3 11.5 9.2 6.4 9.3 9.5 11.7 12.9 12.5 10.6 12.4 10.6 3.6 2.5 3.4 2.4 1.4 1.4 1.2 1.3
Total Current Liabilities 36.9 55.8 21.0 15.1 36.0 38.4 86.2 62.4 48.8 70.8 40.6 14.4 18.3 19.4 22.9 20.3 25.0 21.3 24.9 23.3 17.9 6.5 6.5 6.1 3.5 4.4 4.1 4.8
Long Term Debt 34.5 92.4 144.1 130.1 124.0 115.7 0.2 0.5 0.7 76.1 66.3 33.5 1.9 1.7 3.0 2.4 2.4 3.1 3.0 2.4 1.9 1.5 0.9 1.6 2.1 2.9 3.0 1.7
Deferred Tax Income 0 71.3 0 0 0 0 72.3 134.3 1.4 0 8.9 26.8 0 0 0 0 (0.3) 0 0 (0.9) (14.2) 0 0 0 0 0 0 0
Other Liabilities 5.7 5.7 3.9 4.2 20.6 33.4 81.0 140.4 94.4 2.3 16.0 24.7 17.8 14.0 17.5 20.5 19.0 17.4 9.8 2.3 1.2 2.7 3.3 1.8 0.3 0.3 100 K 0.3
Total Liabilities 77.0 153.9 169.0 149.4 180.6 187.5 167.5 203.4 147.1 149.3 125.8 86.8 39.6 38.3 49.4 43.3 46.8 41.9 37.7 28.9 35.2 10.8 10.6 9.5 5.9 7.5 7.2 6.8
EQUITY
Common Stock 0.9 0.6 0.6 0.6 0.4 0.4 0.4 0.4 6.3 6.2 3.7 3.7 3.6 3.6 3.5 3.5 3.5 3.5 3.4 3.1 3.1 2.4 2.4 2.4 2.0 2.0 0 0
Retained Earnings (745.5) (585.2) (447.8) (384.2) (391.2) (358.0) (263.7) (319.8) (279.8) (320.5) (235.5) (192.6) (189.4) (180.6) (171.6) (160.2) (148.1) (110.4) (75.2) (47.8) (59.9) (56.4) (59.4) (56.5) (47.1) (40.4) (32.5) (25.7)
Other Accumulative Comprehensive Income/Loss (23.2) (26.3) (23.9) (21.1) (22.8) (23.4) (23.3) (23.6) (22.7) (7.4) 10.8 10.3 10.1 10.9 14.5 12.2 14.1 6.5 (2.7) 13.0 1.2 (4.9) (6.6) (6.1) (5.2) (3.2) (5.5) (5.7)
Total Equity 87.7 (21.1) 78.2 162.3 (29.2) 2.8 84.6 42.1 67.9 24.9 (9.5) 30.5 29.8 36.3 44.9 48.5 54.6 73.0 86.7 116.8 92.1 12.3 7.5 10.9 9.1 17.8 14.3 23.1
Total Liabilities and Equity 164.7 132.8 247.3 311.6 151.4 190.3 252.1 245.5 215.0 174.2 116.3 117.3 69.4 74.6 94.3 91.9 101.4 114.9 124.4 145.6 127.3 23.1 18.1 20.4 14.9 25.3 21.5 29.9
SHARES OUTSTANDING
Common Shares Outstanding 80.2 60.1 58.5 53.0 37.4 37.3 40.5 41.2 40.6 36.2 25.4 24.9 24.7 24.4 24.2 24.1 24.0 23.8 23.0 21.5 17.8 16.2 16.2 15.3 12.9 12.0 10.5 8.6